Resurfacing Endoscopic Free Flap for Hereditary Hemorrhagic Telangiectasia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42252661.
- Also identified by DOI 10.1002/hed.70341.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epistaxis related to hereditary hemorrhagic telangiectasia (HHT) can be life-threatening and decreases quality of life (QoL). Current medical and surgical options are limited, particularly in the advanced stages of the disease. We assess the feasibility and outcome of HHT-related epistaxis management by resurfacing the nasal cavity with an endoscopically placed free flap. The Epistaxis Severity Score (ESS) was compared to the preoperative score at one-year post-surgery. The nasal cavity was successfully resurfaced with a radial forearm free flap. The ESS decreased from 8.9 to 3.5 one-year postoperatively. Resurfacing endoscopic free flap (REFF) is a safe and effective procedure for the management of HHT-related epistaxis refractory to other treatment options. Nasal function is maintained, with a significant long-term decrease in epistaxis.